Humanized Mouse Models for Immuno‐oncology Drug Discovery
Authors:
Open Access
- 8 August 2023
- journal article
- research article
- Published by Wiley in Current Protocols
- Vol. 3 (8) , e852
Abstract
Breakthroughs in cancer treatment with immunotherapeutics have provided long‐term patient benefits for many different types of cancer. However, complete response is not achieved in many patients and tumor types, and the mechanisms underlying this lack of response are poorly understood. Despite this, numerous new targets, therapeutics, and drug combinations are being developed and tested in clinical trials. Preclinical models that recapitulate the complex human tumor microenvironment and the interplay between tumor and immune cells within the cancer‐immunity cycle are needed to improve our understanding and screen new therapeutics for efficacy and safety/toxicity. Humanized mice, encompassing human tumors and human immune cells engrafted on immunodeficient mice, have been widely used for many years in immuno‐oncology, with developments to improve both the humanization and the translational value central to the next generation of models. In this overview, we discuss recent advances in humanized models relevant to immuno‐oncology drug discovery, the advantages and limitations of such models, the application of humanized models for efficacy and safety assessments of immunotherapeutics, and the potential opportunities. © 2023 Crown Bioscience. Current Protocols published by Wiley Periodicals LLC.Keywords
This publication has 76 references indexed in Scilit:
- Establishment of a Human Allergy Model Using Human IL-3/GM-CSF–Transgenic NOG MiceThe Journal of Immunology, 2013
- Humanized mice for the study of infectious diseasesCurrent Opinion in Immunology, 2013
- Graft versus Host Disease in the Bone Marrow, Liver and Thymus Humanized Mouse ModelPLOS ONE, 2012
- Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγnull Mice Display a T-Effector Memory PhenotypePLOS ONE, 2012
- Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapiesOncogene, 2012
- Superior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2Rγ−/− (NSG) BLT miceVirology, 2011
- Functional CD47/signal regulatory protein alpha (SIRPα) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivoProceedings of the National Academy of Sciences, 2011
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic CellsScience, 2007
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- High Levels of Human Peripheral Blood Mononuclear Cell Engraftment and Enhanced Susceptibility to Human Immunodeficiency Virus Type 1 Infection in NOD/LtSz-scid/scid MiceThe Journal of Infectious Diseases, 1995